Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human breast cancer cells: control vs treated with breast cancer patients' sera

ABSTRACT: To investigate the significant differently expressed genes upon the stimulation of breast cancer patients' sera.

ORGANISM(S): Homo sapiens

PROVIDER: GSE40108 | GEO | 2012/08/15

SECONDARY ACCESSION(S): PRJNA172845

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Human breast cancer cells: control vs treated with breast cancer patients' sera

Project description:To investigate the significant differently expressed genes upon the stimulation of breast cancer patients' sera. Cells were untreated or treated with 10% breast cancer patients' sera for 24h followed by isolation of total RNA using TRIZOL. Gene-expression profiling was performed on the CapitalBio 35k human Genome Array microchips (Beijing, China).

2012-08-14 | E-GEOD-40108 | biostudies-arrayexpress

Human breast cancer cells: control vs treated with breast cancer patients' sera

| S-ECPF-GEOD-40108 | biostudies-other

Transcription profiling of human leukemia cell lines treated with sera from Type I diabetes patients to investigate sera-induced transcriptional signatures.

Project description:Inflammation is common to many disorders and responsible for tissue and organ damage. However, the associated peripheral cytokine milieu is frequently dilute and difficult to measure, necessitating development of more sensitive and informative biomarkers for mechanistic studies, earlier diagnosis, and monitoring therapeutic interventions. Previously, we have shown that sera from type 1 diabetes (T1D) patients induces a unique disease-specific pro-inflammatory transcriptional profile in fresh peripheral blood mononuclear cells (PBMCs) compared to sera of healthy controls. To address the potential variance introduced by heterogeneity in responsiveness of PBMCs from different donors, we evaluated human leukemia cell lines as surrogates for fresh PBMCs. Expression signatures of 7 different cell lines were 1) tested in their power to differentiate sera of T1D patients from healthy controls; and 2) compared to the signature obtained with fresh PBMCs. For each of the 7 cell lines, we assayed 6 individual samples (three stimulated with recent-onset (RO) T1D sera and three stimulated with healthy control sera). Hence, a total of 42 samples were analyzed in this study.

2010-09-16 | E-GEOD-24147 | biostudies-arrayexpress

SSc sera stimulated HDEC culture time course

Project description:This series represents HDEC cultured in 10% control sera vs. SSc sera with ACA vs. SSc sera with SCL70 Samples were analyzed at 1, 6, 12, and 24 hours The data that have been provided in the GEO Samples (GSMs) are from QuantArray. The values indicated under the VALUE header were obtained by taking the log (base 2) of the ratio of the raw data from the experimental samples to the reference RNA samples. These raw data were subsequently analyzed by Cluster and TreeView which normalizes the data across samples (see appended Table). The normalization procedure was as follows: Background corrected intensity expression levels were normalized per channel using the software program called Cluster as follows: one cycle of log transformation, five cycles of median centering of genes, and five cycles of normalizing genes to generate a log-transformed, median polished, and normal (magnitudes close to 1.0) dataset. Keywords = HDEC, SSc sera stimulation Keywords: time-course

2005-07-30 | GSE2710 | GEO

SSc sera stimulated HDEC culture time course

2010-06-09 | E-GEOD-2710 | biostudies-arrayexpress

Use of UHPLC-HRMS to profile the metabolites from the serum of breast cancer patients

Project description:<p>Breast cancer (BC) is the most common malignancy and the leading cause of cancer-related mortality in women worldwide. As such exploring the metabolic changes during human breast carcinogenesis is important for developing disease prevention methods and treatments. In the present study, non-targeted metabolomics with chemometrics based on ultrahigh performance liquid chromatography-high resolution mass spectrometry was conducted to analyze the differences in serum metabolite patterns between female patients with BC and healthy individuals. A total of 3246 metabolites at various concentrations in the sera of healthy controls and patients with BC were found. Kyoto Encyclopedia of Genes and Genomes pathway analysis demonstrated that arginine, proline, nicotinate, nicotinamide, caffeine and arachidonic acid metabolism as well as fatty acid biosynthesis were significantly altered in BC patients in comparison to controls. These results suggest that serum metabolic profiling has great potential in discovering molecular biomarkers for the detection of BC breast cancer. They may also help to further our understanding of the underlying mechanisms associated with this debilitating disease.</p>

2024-02-13 | MTBLS8920 | MetaboLights

Autoantibodies in sera from Sjogren's syndrome mice

Project description:We performed autoantigen arrays on sera derived from Sjogren's syndrome mice that lacked Myd88 systemically (NOD.B10LSL-/- strain) or lacked Myd88 in specific tissues (NOD.B10Myd88delta and NOD.B10LSL-/-Vav+ strains). We also examined sera from Myd88-sufficient controls (NOD.B10Myd88fl/fl, NOD.B10, and NOD.B10LSL+/- strains).

2021-01-25 | GSE163395 | GEO

Actinocatenispora sera strain:NBRC 101916

Project description:Actinocatenispora sera NBRC 101916 genome sequencing project

| PRJDB9576 | ENA

Evaluation of auto-antibody serum biomarkers for breast cancer screening

Project description:Using protein microarrays, derived from 642 His-tag proteins, we could distinguish sera from breast-nodule positive patients and healthy control individuals.

2011-12-21 | GSE34555 | GEO

miRNAs associated with breast cancer brain metastasis

Project description:The goal of this study is to determine the extracellular miRNAs associated with breast cancer metastasis to the brain. By combining the small RNA-seq data of patient sera and cell culture models, we are able to select breast cancer cell-derived miRNAs that are associated with brain metastasis for further functional study.

2023-11-01 | GSE216934 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data